1. Home
  2. CRS vs EXAS Comparison

CRS vs EXAS Comparison

Compare CRS & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRS
  • EXAS
  • Stock Information
  • Founded
  • CRS 1910
  • EXAS 1995
  • Country
  • CRS United States
  • EXAS United States
  • Employees
  • CRS N/A
  • EXAS N/A
  • Industry
  • CRS Steel/Iron Ore
  • EXAS Medical Specialities
  • Sector
  • CRS Industrials
  • EXAS Health Care
  • Exchange
  • CRS Nasdaq
  • EXAS Nasdaq
  • Market Cap
  • CRS 12.2B
  • EXAS 10.2B
  • IPO Year
  • CRS N/A
  • EXAS N/A
  • Fundamental
  • Price
  • CRS $239.89
  • EXAS $53.94
  • Analyst Decision
  • CRS Strong Buy
  • EXAS Strong Buy
  • Analyst Count
  • CRS 2
  • EXAS 22
  • Target Price
  • CRS $302.50
  • EXAS $67.38
  • AVG Volume (30 Days)
  • CRS 822.6K
  • EXAS 3.0M
  • Earning Date
  • CRS 10-23-2025
  • EXAS 11-04-2025
  • Dividend Yield
  • CRS 0.33%
  • EXAS N/A
  • EPS Growth
  • CRS 100.54
  • EXAS N/A
  • EPS
  • CRS 7.42
  • EXAS N/A
  • Revenue
  • CRS $2,877,100,000.00
  • EXAS $2,939,949,000.00
  • Revenue This Year
  • CRS $10.39
  • EXAS $16.50
  • Revenue Next Year
  • CRS $9.95
  • EXAS $12.32
  • P/E Ratio
  • CRS $32.35
  • EXAS N/A
  • Revenue Growth
  • CRS 4.25
  • EXAS 12.55
  • 52 Week Low
  • CRS $136.05
  • EXAS $38.81
  • 52 Week High
  • CRS $290.84
  • EXAS $72.83
  • Technical
  • Relative Strength Index (RSI)
  • CRS 43.05
  • EXAS 63.63
  • Support Level
  • CRS $243.38
  • EXAS $46.30
  • Resistance Level
  • CRS $255.99
  • EXAS $56.52
  • Average True Range (ATR)
  • CRS 6.44
  • EXAS 1.67
  • MACD
  • CRS 1.00
  • EXAS 0.91
  • Stochastic Oscillator
  • CRS 34.76
  • EXAS 76.84

About CRS Carpenter Technology Corporation

Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: